[1] 荆林凯,于贝贝,张会芳,等.高级别脊髓胶质瘤的生存预后及其影响因素分析[J].中华神经外科杂志,2021,37(12):1251~1256.
[2] Tunthanathip T,Ratanalert S,Sae-Heng S,et al.Prognostic factors and clinical nomogram predicting survival in high-grade glioma[J].J Cancer Res Ther,2021,17(4):1052~1058.
[3] Sun Y,Xiong ZY,Yan PF,et al.Characteristics and prognostic factors of age-stratified high-grade intracranial glioma patients: A population-based analysis[J].Bosn J Basic Med Sci,2019,19(4):375~383.
[4] 杨凯元,满韦韬.脊髓胶质瘤治疗及预后相关因素的研究现状[J].中国微侵袭神经外科杂志,2021,26(6):282~285.
[5] Leibetseder A,Leitner J,Mair MJ,et al.Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature[J].J Neurol,2022,269(3):1574~1590.
[6] Chowdhury S,Sarkar RR,et al.Exploring Notch Pathway to Elucidate Phenotypic Plasticity and Intra-tumor Heterogeneity in Gliomas[J].Sci Rep,2019,9(1):9488.
[7] 《中国中枢神经系统胶质瘤诊断和治疗指南》编写组.中国中枢神经系统胶质瘤诊断与治疗指南(2015)[J].中华医学杂志,2016,96(7):485~509.
[8] Yanming L,Yue C,Wencan C,et al.Combined detection of AFP-L3,GP73 and TIP30 enhances diagnostic accuracy for HBV-related cirrhosis and hepatocellular carcinoma[J].J Pak Med Assoc,2019,69(9):1279~1286.
[9] Szivos L,Virga J,Klekner Ȃ,et al.The role of low grade glioma prognostic factors in therapeutic choices - summary of international literature and recommendations with conclusions[J].Magy Onkol,2021,65(1):59~70.
[10] Parmigiani E,Taylor V,Giachino C.Oncogenic and Tumor-Suppressive Functions of NOTCH Signaling in Glioma[J].Cells,2020,9(10):2304.
[11] 袁英淇,闫润芝,范益民.IFI 30、PD-L1在人神经胶质瘤中的表达及与病人预后的关系[J].中国临床神经外科杂志,2021,26(11):835~838.
[12] Chen KY,Bush K,Klein RH,et al.Reciprocal H3.3 gene editing identifies K27M and G34R mechanisms in pediatric glioma including NOTCH signaling[J].Commun Biol,2020,3(1):363.
[13] Elmaraghi C,Bishr MK,Mousa AG,et al.Pediatric low grade focal brainstem glioma: outcomes of different treatment strategies and prognostic factors[J].Future Oncol,2020,16(30):2401~2410.
[14] Maimaiti A,Wang X,Hao Y,et al.Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma[J].J Mol Neurosci,2021,71(8):1622~1635.
[15] 赵征,孙志延,吴凡,等.Delta样典型Notch配体3基因在神经胶质瘤中的表达及其临床意义[J].中华神经外科杂志,2021,37(7):721~727.
[16] Grund A,Szaroszyk M,Korf-Klingebiel M,et al.TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation[J].EMBO Mol Med,2019,11(10):e10018.
[17] Hu Y,Chen F,Liu F,et al.Overexpression of TIP30 inhibits the growth and invasion of glioma cells[J].Mol Med Rep,2016,13(1):605~612.
[18] 马菁昌,时光旭,王莉,等.Notch信号通路在神经胶质瘤中的作用与机制研究进展[J].临床神经外科杂志,2020,17(4):477~480.
[19] Noor H,Whittaker S,McDonald KL,et al.DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis[J].Genomics,2022,114(2):110289.
[20] Feng Y,Wang J,Tan D,et al.Relationship between circulating inflammatory factors and glioma risk and prognosis: A meta-analysis[J].Cancer Med,2019,8(17):7454~7468.
[21] 吴浩,张恒柱.影响神经胶质瘤预后的关键信号通路调控机制研究进展[J].国际外科学杂志,2022,49(1):57~62.
[22] Ouyang T,Meng W,Li M,et al.Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma[J].Cell Mol Neurobiol,2020,40(4):495~510.
[23] Spino M,Kurz SC,Chiriboga L,et al.Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant Glioma[J].Clin Cancer Res,2019,25(4):1261~1271.
[24] 李元元,朱淑霞,张园园,等.沉默FOXC1基因调控Notch通路对脑胶质瘤细胞增殖和凋亡影响[J].中华肿瘤防治杂志,2019,26(14):997~1002. |